Baidu
map

内分泌科

订阅

MedSci主页 / 所有栏目 / 内分泌科

IDF 2015：全世界共有4.15亿成年人患有糖尿病，中国1.1亿人

2015-12-09 MedSci MedSci原创

糖尿病IDF世界2015
关注

根据国际糖尿病联盟(IDF)12月1日在“2015年世界糖尿病大会”上最新发布的第7版糖尿病概览(Diabetes Atlas)（点击下载全文），世界范围内共有4.15亿成年人患有糖尿病，即每11人中便有1人患有糖尿病。该最新版结合了糖尿病类型，显示自从2013年发布的上版概览以来，全世界共增加了3.1千万的成年糖尿病患者。发病率和患病率12月1日，美国糖尿病控制与预防中心发布的最新数据表明，美国

根据国际糖尿病联盟(IDF)12月1日在“2015年世界糖尿病大会”上最新发布的第7版尿病概览(Diabetes Atlas)（点击下载全文）糖，世界范围内共有4.15亿成年人患有糖尿病，即每11人中便有1人患有糖尿病。该最新版结合了糖尿病类型，显示自从2013年发布的上版概览以来，全世界共增加了3.1千万的成年糖尿病患者（WHO 2012：全世界有3.47亿人患有糖尿病）。发病率和患病率12月1日，美国糖尿病控制与预防中心发布的最新数据表明，美国18~79岁的成人在校正年龄因素后，糖尿病发病率从1990~2008年增长超过两倍后，2008~2014年间实际上在明显降低，***发病率从8.5降到了6.6。但是根据IDF概览，美国20岁~79岁的成人患病率为11%，在发达国家中仍然是最高的。但是IDF数据分析专家Katherine Ogurtsova博士指出，CDC(糖尿病控制中心)的发病率数据不能直接与IDF概览的患病率数据进行比较，因为两者的计算方法不一样。同时认为，如果未来没有巨大变革发生，患病率不可能有降低的趋势。美国的糖尿病患病率仍将升高，即使新增发病人数越来越少，她解释说，因

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2021-12-20 419040982

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2021-12-17 星痕

    惊人的数字

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2016-11-22 hxzhang

    #IDF#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2016-03-20 新生儿张玉军

    #全世界#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2016-02-04 wei834766788

    值得关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2016-01-04 xyfg98

    赞

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-26 hixiaoluo

    好文章，值得看。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-18 惜言

    糖人

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-11 medcardio

    中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1082244, encodeId=55731082244bf, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a44885671, createdName=419040982, createdTime=Mon Dec 20 22:25:52 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081123, encodeId=68b3108112330, content=惊人的数字, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/1e37b07b849346038be41fe1dac7282c/3397137c98a4401787227b3a9565d458.jpg, createdBy=28372103731, createdName=星痕, createdTime=Fri Dec 17 12:23:52 CST 2021, time=2021-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675466, encodeId=901816e54665c, content=<a href='/topic/show?id=8f1d941219' target=_blank style='color:#2F92EE;'>#IDF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9412, encryptionId=8f1d941219, topicName=IDF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ca2627235272, createdName=hxzhang, createdTime=Tue Nov 22 15:11:00 CST 2016, time=2016-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2005999, encodeId=40bd200599957, content=<a href='/topic/show?id=68d629292b6' target=_blank style='color:#2F92EE;'>#全世界#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29292, encryptionId=68d629292b6, topicName=全世界)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKnILSXam1GxPwj04ylEzibYLFA2eGl5Ev02klt80JA0xejMPqrn0mYHNNnLEgyqYTPbicXpY3tn6SA/132, createdBy=38fd2500059, createdName=新生儿张玉军, createdTime=Sun Mar 20 06:11:00 CST 2016, time=2016-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=63198, encodeId=3209631980d, content=值得关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=196, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Thu Feb 04 11:39:00 CST 2016, time=2016-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=51827, encodeId=fe825182e6f, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe261399236, createdName=xyfg98, createdTime=Mon Jan 04 18:29:00 CST 2016, time=2016-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=48576, encodeId=9a94485e652, content=好文章，值得看。, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sat Dec 26 17:37:00 CST 2015, time=2015-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=46583, encodeId=72ab4658369, content=糖人, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 18 09:48:00 CST 2015, time=2015-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45606, encodeId=258e456068d, content=中国未来糖尿病人群可能还会大幅度增加，这是非常可怕的一种现实, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Fri Dec 11 20:24:00 CST 2015, time=2015-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=45534, encodeId=85fa455346c, content=这么多, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=974f1667182, createdName=杨晨舟, createdTime=Fri Dec 11 10:39:00 CST 2015, time=2015-12-11, status=1, ipAttribution=)]
    2015-12-11 杨晨舟

    这么多

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

阿布扎比会议呼吁关注糖尿病相关骨病变

糖尿病是普遍存在的慢性疾病,在中东地区是一个越来越重要的公共卫生问题。治疗糖尿病的医生常常不认识糖尿病的并发症——脆性骨折。为了应对该地区急剧增加的脆弱性骨折和2型糖尿病(T2DM)患者，在阿布扎比举行的第三届中东和非洲骨质疏松症会议上，将糖尿病和脆性骨折的关系作为重中之重。先前有关糖尿病和骨质疏松症的工作会议，专家汇报了糖尿病相关骨疾病的流行病学、病理生理学、和管理等最新信息。此外还汇报了来自伊

FDA警告：糖尿病治疗新秀“SGLT2抑制剂”导致酮症酸中毒风险

近年来,钠-葡萄糖2型转运体(SGLT2)作为一个治疗糖尿病的新靶点受到广泛关注。SGLT2是一类特异性分布在肾脏近曲小管S1段的葡萄糖转运体,其生理功能是负责约90%葡萄糖的重吸收。SGLT2抑制剂通过抑制SGLT2,从而减少肾脏对葡萄糖的重吸收,增加尿糖排出,降低血糖。近期FDA更新SGLT2抑制剂标签，强调该药物酮症酸中毒和严重的尿路感染风险，这两种疾病均会导致住院治疗。2015年5月，FD

Circulation：2-型糖尿病患者中，女性比男性更容易出现心血管疾病！

在以往的研究中，人们已经发现糖尿病患者患心血管疾病风险相对于常人较高，但美国心脏病协会最近发表的一份新的研究报告称，在2-型糖尿病患者中女性相对于男性更容易出现心血管疾病。

NEJM新闻：快讯！每周一次GLP-1RAs，治疗2型糖尿病

Annals of Internal Medicine发表网状Meta分析显示，GLP-1RAs（ glucagon-like peptide-1 receptor agonists，胰高血糖素样蛋白-1受体激动剂）度拉糖肽（Dulaglutide）、艾塞那肽（Exenatide）和他司鲁泰（Taspoglutide）可以最大程度降低糖尿病患者HbA1c（hemoglobin A1c，糖化血红蛋白

AIM：GLP-1RAs治疗2型糖尿病—受益和损害

与其他每周一次GLP-1RAs相比，dulaglutide （1.5mg）、每周一次exenatide和taspoglutide（20mg）具有较大程度降低HbA1c、空腹血糖和体重的效果。Taspoglutide （20mg）使用者发生恶心的风险最高。每周一次GLP-1RAs类药物使用者发生低血糖的风险相似。

Am J Epidemiol：常喝咖啡能减少2型糖尿病风险，降低全因死亡

http://www.medicalnewstoday.com/articles/303548.php

Baidu
map
Baidu
map
Baidu
map